Summary of Study ST002568

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001655. The data can be accessed directly via it's Project DOI: 10.21228/M8S726 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002568
Study TitleAssessment of metabolic changes in different animal models of maladaptive right ventricular hypertrophy in chronic pulmonary hypertension by lipidomics and HILIC
Study SummaryWe analyzed plasma samples from 33 Yucatan pigs belonging to four different experimental models of pulmonary hypertension (PH): M1 chronic postcapillary PH by pulmonary vein banding; M2 chronic PH by aorto-pulmonary shunting; M3: right ventricular pressure overload by pulmonary artery banding, thus without PH; and M0 sham procedure. Briefly, blood samples were collected 8 months after surgery and untargeted lipidomics and HILIC metabolomic analyses were performed for negative and positive polarities. For quality control, 5 QC samples were included in each analysis, iterative MSMS was performed for metabolite annotation. Plasma metabolomic patterns differed among groups, displaying arginine-nitric oxide and histidine deficiency in both PH models (M1 and M2), altered taurine and purine pathways in M2, and lipidomic changes in all three models of pressure overload.
Institute
Universidad CEU San Pablo
Last NameMoran
First NameMaria
AddressUniversidad CEU-San Pablo. Urb. Montepríncipe
Emailmaria.morangarrido@ceu.es
Phone913724769
Submit Date2023-03-23
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2023-05-10
Release Version1
Maria Moran Maria Moran
https://dx.doi.org/10.21228/M8S726
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:

Project:

Project ID:PR001655
Project DOI:doi: 10.21228/M8S726
Project Title:Pulmonary hypertension metabolomics
Project Summary:Identify relevant mechanisms associated to maladaptive right ventricular hypertrophy in pulmonary hypertension, beyond pressure overload, through the integration of advanced imaging and omics.
Institute:Universidad CEU San Pablo
Last Name:Moran
First Name:Maria
Address:Universidad CEU-San Pablo. Urb. Montepríncipe
Email:maria.morangarrido@ceu.es
Phone:913724769

Subject:

Subject ID:SU002669
Subject Type:Mammal
Subject Species:Sus scrofa
Taxonomy ID:9823

Factors:

Subject type: Mammal; Subject species: Sus scrofa (Factor headings shown in green)

mb_sample_id local_sample_id Model
SA258095B0_2992_HILIC_negativeM0
SA258096A0_7611_HILIC_positiveM0
SA258097A0_7573_HILIC_positiveM0
SA258098B0_2995_Lipidomics_negativeM0
SA258099B0_3219_Lipidomics_negativeM0
SA258100B0_5023_Lipidomics_negativeM0
SA258101B0_5021_Lipidomics_negativeM0
SA258102A0_7348_HILIC_positiveM0
SA258103B0_3216_Lipidomics_negativeM0
SA258104A0_6952_HILIC_positiveM0
SA258105B0_3219_HILIC_positiveM0
SA258106B0_3216_HILIC_positiveM0
SA258107B0_2995_HILIC_positiveM0
SA258108B0_5021_HILIC_positiveM0
SA258109B0_5023_HILIC_positiveM0
SA258110B0_5247_HILIC_positiveM0
SA258111B0_5194_HILIC_positiveM0
SA258112B0_5194_Lipidomics_negativeM0
SA258113B0_5247_Lipidomics_negativeM0
SA258114B0_5247_Lipidomics_positiveM0
SA258115B0_5194_Lipidomics_positiveM0
SA258116B0_5023_Lipidomics_positiveM0
SA258117A0_6952_Lipidomics_positiveM0
SA258118A0_7348_Lipidomics_positiveM0
SA258119A0_7611_Lipidomics_positiveM0
SA258120A0_7573_Lipidomics_positiveM0
SA258121B0_5021_Lipidomics_positiveM0
SA258122B0_3219_Lipidomics_positiveM0
SA258123A0_7573_Lipidomics_negativeM0
SA258124A0_7348_Lipidomics_negativeM0
SA258125A0_6952_Lipidomics_negativeM0
SA258126A0_7611_Lipidomics_negativeM0
SA258127B0_2992_Lipidomics_positiveM0
SA258128B0_3216_Lipidomics_positiveM0
SA258129B0_2995_Lipidomics_positiveM0
SA258130B0_2992_HILIC_positiveM0
SA258131B0_2992_Lipidomics_negativeM0
SA258132B0_5194_HILIC_negativeM0
SA258133B0_5021_HILIC_negativeM0
SA258134B0_3219_HILIC_negativeM0
SA258135B0_5247_HILIC_negativeM0
SA258136A0_6952_HILIC_negativeM0
SA258137A0_7611_HILIC_negativeM0
SA258138A0_7573_HILIC_negativeM0
SA258139A0_7348_HILIC_negativeM0
SA258140B0_3216_HILIC_negativeM0
SA258141B0_5023_HILIC_negativeM0
SA258142B0_2995_HILIC_negativeM0
SA258143B1_3796_HILIC_negativeM1
SA258144B1_3800_HILIC_negativeM1
SA258145B1_3801_Lipidomics_positiveM1
SA258146A1_7050_HILIC_negativeM1
SA258147A1_7049_HILIC_negativeM1
SA258148B1_3801_HILIC_negativeM1
SA258149B1_3796_Lipidomics_negativeM1
SA258150A1_7575_Lipidomics_negativeM1
SA258151A1_7130_Lipidomics_negativeM1
SA258152A1_7049_Lipidomics_negativeM1
SA258153B1_3801_Lipidomics_negativeM1
SA258154B1_3800_Lipidomics_negativeM1
SA258155A1_7130_HILIC_negativeM1
SA258156A1_7575_Lipidomics_positiveM1
SA258157B1_3800_HILIC_positiveM1
SA258158B1_3801_HILIC_positiveM1
SA258159B1_3796_HILIC_positiveM1
SA258160A1_7049_Lipidomics_positiveM1
SA258161B1_3800_Lipidomics_positiveM1
SA258162B1_3796_Lipidomics_positiveM1
SA258163A1_7049_HILIC_positiveM1
SA258164A1_7050_HILIC_positiveM1
SA258165A1_7130_Lipidomics_positiveM1
SA258166A1_7575_HILIC_negativeM1
SA258167A1_7050_Lipidomics_positiveM1
SA258168A1_7575_HILIC_positiveM1
SA258169A1_7130_HILIC_positiveM1
SA258170A1_7050_Lipidomics_negativeM1
SA258171B2_7350_Lipidomics_positiveM2
SA258172A2_7743_Lipidomics_positiveM2
SA258173B2_7152_Lipidomics_positiveM2
SA258174A2_6680_Lipidomics_positiveM2
SA258175A2_7344_Lipidomics_positiveM2
SA258176B2_7350_Lipidomics_negativeM2
SA258177A2_7743_Lipidomics_negativeM2
SA258178B2_7152_Lipidomics_negativeM2
SA258179A2_7344_Lipidomics_negativeM2
SA258180A2_6680_Lipidomics_negativeM2
SA258181B2_7350_HILIC_negativeM2
SA258182B2_7350_HILIC_positiveM2
SA258183B2_7152_HILIC_negativeM2
SA258184A2_7743_HILIC_negativeM2
SA258185A2_6680_HILIC_positiveM2
SA258186A2_7344_HILIC_negativeM2
SA258187A2_7743_HILIC_positiveM2
SA258188B2_7152_HILIC_positiveM2
SA258189A2_7344_HILIC_positiveM2
SA258190A2_6680_HILIC_negativeM2
SA258191A2_6701_HILIC_negativeM3
SA258192A2_6701_HILIC_positiveM3
SA258193B3_2600_HILIC_positiveM3
SA258194B3_5248_HILIC_positiveM3
Showing page 1 of 2     Results:    1  2  Next     Showing results 1 to 100 of 160

Collection:

Collection ID:CO002662
Collection Summary:Blood samples were collected during a right heart catheterization from the pulmonary artery and plasma was formed and frozen at -80ºC.
Sample Type:Blood (plasma)

Treatment:

Treatment ID:TR002681
Treatment Summary:Four different experimental models were generated: M1: a model of chronic postcapillary pulmonary hypertension by surgical nonrestrictive banding of the pulmonary veins; M2: a model of chronic pulmonary hypertension by aorto-pulmonary shunting; M3: a model of right ventricular pressure overload without pulmonary hypertension by pulmonary artery banding; and M0 a sham procedure.

Sample Preparation:

Sampleprep ID:SP002675
Sampleprep Summary:For the lipidomics protocol 800μl of a solvent mixture with internal standard (made from 75ml chloroform, 75 ml MTBE,100ml MeOH,937.5ul D-palmitic acid and 40 μl C17-sphinganine) were added to 40μl of plasma. Samples were vortexed for 30 seconds, then they were shaken at 1000rpm for 20 min at room temperature, finally they were centrifuged 5 min at 3000 rpm and supernatant was transferred to LC-MS vials. For the HILIC sample preparation 300μl of MeOH were added to 100μl of plasma and it was vortexed for 2 minutes. Samples were left on ice for 10 minutes and then centrifuged at 18,670 g for 10 minutes at 4ºC. Finally, the supernatant was collected and transferred to an LC-MS vial.

Combined analysis:

Analysis ID AN004229 AN004230 AN004231 AN004232
Analysis type MS MS MS MS
Chromatography type Reversed phase Reversed phase HILIC HILIC
Chromatography system Agilent 1290 Infinity II Agilent 1290 Infinity II Agilent 1290 Infinity II Agilent 1290 Infinity II
Column Agilent InfinityLab Poroshell 120 EC-C18 (100 x 3mm,2.7um) Agilent InfinityLab Poroshell 120 EC-C18 (100 x 3mm,2.7um) Waters XBridge BEH Amide (100 x 2.1mm,2.5um) Waters XBridge BEH Amide (100 x 2.1mm,2.5um)
MS Type ESI ESI ESI ESI
MS instrument type QTOF QTOF QTOF QTOF
MS instrument name Agilent 6545 QTOF Agilent 6545 QTOF Agilent 6560 Ion Mobility Agilent 6545 QTOF
Ion Mode POSITIVE NEGATIVE NEGATIVE POSITIVE
Units Peak area Peak area Peak area Peak area

Chromatography:

Chromatography ID:CH003138
Instrument Name:Agilent 1290 Infinity II
Column Name:Agilent InfinityLab Poroshell 120 EC-C18 (100 x 3mm,2.7um)
Column Temperature:50 °C
Flow Gradient:0.0-1.0 min: 70% B, 1.0-3.5 min: 86% B, 3.5-10 min: 86% B, 10.0-11.0 min: 100% B, 11.0-17.0 100% B, 17.0-19.0 min: 70% B
Flow Rate:0.6 mL/min
Solvent A:90% water/1% methanol, 10 mM ammonium acetate, 0.2 mM ammonium fluoride
Solvent B:20% acetonitrile/30% methanol/50% isopropanol, 10 mM ammonium acetate, 0.2 mM ammonium fluoride
Chromatography Type:Reversed phase
  
Chromatography ID:CH003139
Instrument Name:Agilent 1290 Infinity II
Column Name:Waters XBridge BEH Amide (100 x 2.1mm,2.5um)
Column Temperature:25 ºC
Flow Gradient:0.0-2.0 min: 96% B, 2.0-5.5 min: 88% B, 5.5- 8.5 min: 88% B, 8.5-9.0 min: 86% B, 9.0-14.0 min: 86% B, 14.0-17.0 min: 82% B, 17.0-23.0 min: 65% B, 23.0-24.0 min: 65%B, 24.0-24.5 min: 96% B, 24.5-29.0 min: 96% B
Flow Rate:0.25 mL/min
Solvent A:100% water, 10 mM ammonium acetate, 2.5 μM InfinityLab deactivator additive (Agilent, P-N. 5191-4506)
Solvent B:15% water/85% acetonitrile, 10 mM ammonium acetate, 2.5 μM InfinityLab deactivator additive (Agilent, P-N. 5191-4506)
Chromatography Type:HILIC
  
Chromatography ID:CH003140
Instrument Name:Agilent 1290 Infinity II
Column Name:Waters XBridge BEH Amide (100 x 2.1mm,2.5um)
Column Temperature:25 ºC
Flow Gradient:0.0-3.0min: 98% B, 3.0-6.0 min: 98% B, 6.0-11.0 min: 70% B, 11.0-12.0 min: 60%, 12.0-16.0 min: 5% B, 16.0-18.0 min: 5% B, 18.0-19.0 min: 98% B and 0.1% formic acid
Flow Rate:0.25 mL/min
Solvent A:100% water, 10 mM ammonium formate ,2.5 μM InfinityLab deactivator additive (Agilent, P-N. 5191-4506) and 0.1% formic acid
Solvent B:in 10% water/90% acetonitrile, 10 mM ammonium formate 2.5 μM InfinityLab deactivator additive (Agilent, P-N. 5191-4506)
Chromatography Type:HILIC

MS:

MS ID:MS003976
Analysis ID:AN004229
Instrument Name:Agilent 6545 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:the gas temperature in the ion source was 200 ºC, the flow was 10 L/min, the pressure in the nebulizer was 50 psig, the temperature of the sheath gas was 300 ºC and the flow of the sheath gas was 12 L/min. The voltage of the capillary was set at 3500 V, the nozzle voltage was 0 L/min, the fragmentor was set at 150 V in the 6545 system and at 400 V in the 6560 system, the voltage in the skimmer was 65 V and the OctopoleRFPeak was 750. After data acquisition, the data files were inspected using Agilent MassHunter Qualitative 10. MassHunter Profinder 10 was used for alignment of data, the deconvolution process and peak integration. MassHunter Lipid Annotator was used to assist in the lipid identification process, features were tentatively annotated based on the MS1 data using the online toll CEU Mass Mediator.
Ion Mode:POSITIVE
  
MS ID:MS003977
Analysis ID:AN004230
Instrument Name:Agilent 6545 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:the gas temperature in the ion source was 200 ºC, the flow was 10 L/min, the pressure in the nebulizer was 50 psig, the temperature of the sheath gas was 300 ºC and the flow of the sheath gas was 12 L/min. The voltage of the capillary was set at 3000 V, the nozzle voltage was 0 L/min, the fragmentor was set at 150 V in the 6545 system and at 400 V in the 6560 system, the voltage in the skimmer was 65 V and the OctopoleRFPeak was 750.After data acquisition, the data files were inspected using Agilent MassHunter Qualitative 10. MassHunter Profinder 10 was used for alignment of data, the deconvolution process and peak integration. MassHunter Lipid Annotator was used to assist in the lipid identification process, features were tentatively annotated based on the MS1 data using the online toll CEU Mass Mediator.
Ion Mode:NEGATIVE
  
MS ID:MS003978
Analysis ID:AN004231
Instrument Name:Agilent 6560 Ion Mobility
Instrument Type:QTOF
MS Type:ESI
MS Comments:The gas temperature in the ion source was 225 ºC, the flow was 13 L/min, the pressure in the nebulizer was 35 psig, the temperature of the sheath gas was 350 ºC and the flow of the sheath gas was 12 L/min. The voltage of the capillary was set at 3500 V, the nozzle voltage was 0 L/min, the fragmentor was set at 125 V in the 6545 system and at 400 V in the 6560 system, the voltage in the skimmer was 45 V and the OctopoleRFPeak was 750. After data acquisition, the data files were inspected using Agilent MassHunter Qualitative 10. MassHunter Profinder 10 was used for alignment of data, the deconvolution process and peak integration. Features were tentatively annotated based on the MS1 data using the online toll CEU Mass Mediator.
Ion Mode:NEGATIVE
  
MS ID:MS003979
Analysis ID:AN004232
Instrument Name:Agilent 6545 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:The gas temperature in the ion source was 225 ºC, the flow was 13 L/min, the pressure in the nebulizer was 35 psig, the temperature of the sheath gas was 350 ºC and the flow of the sheath gas was 12 L/min. The voltage of the capillary was set at 3500 V, the nozzle voltage was 0 L/min, the fragmentor was set at 125 V in the 6545 system and at 400 V in the 6560 system, the voltage in the skimmer was 45 V and the OctopoleRFPeak was 750. Features were tentatively annotated based on the MS1 data using the online toll CEU Mass Mediator.
Ion Mode:POSITIVE
  logo